Ledger.Open graph →

SEC Form D · filed August 8, 2023

Quadrant Biosciences Inc

Offering

$35.0M

Sold

$3.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SYRACUSE, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Erica Ash · Syracuse, NYExec Richard Bongo · Syracuse, NYExec · Director James Croke · Syracuse, NYExec · Director Andrew Rock · Syracuse, NYDirector Bryan Greene · Syracuse, NYExec Richard Uhlig · Syracuse, NYExec · Director Ira Fedder · Syracuse, NYDirector Mary Ann Tyszko · Syracuse, NYDirector Peter Cohen · Syracuse, NYDirector Nicholas Gianadda · Syracuse, NYExec Mark A. Patton · Dallas, TXExec · Director Nicholas Gianadda · Syracuse, NYExec Erica Ash · Syracuse, NYExec Allyson Pritchett · Austin, TXExec · Director Samuel Zoske · Washington, IADirector Adam Koppes · Washington, IAExec Todd Thompson · Washington, IADirector Alfred T. Sanford · Boston, MADirector Theodore E. Pritchett Iii · Austin, TXExec · Director Samuel W. Inman · Atlanta, GADirector Melvin Herdrick · Vancouver, British Columbia, CanadaExec · Director Hendrik Van Alphen · Vancouver, British Columbia, CanadaExec · Director Craig Roberts · Vancouver, British Columbia, CanadaExec · Director Thomas T. Soviero · NEW YORK, NYExec Vanessa F. Barrett · GRAND CAYMAN, Cayman IslandsDirector William M. Bott · Bethesda, MDDirector Scott J. Boxer · Frisco, TXDirector Anthony D. Notargiacomo · The Woodlands, TXDirector Kyle Ferguson · Las Vegas, NVExec a Delaware limited liability company Twenty Two Ventures GP VI, LLC · Palo Alto, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗